Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Aandeel

Pharming Group NL0010391025

Laatste koers (eur)

0,882
  • Verschill

    +0,006 +0,63%
  • Volume

    1.528.947 Gem. (3M) 6,7M
  • Bied

    0,883  
  • Laat

    0,883  
+ Toevoegen aan watchlist

Grafische analyse

97 Posts
Pagina: «« 1 2 3 4 5 »» | Laatste | Omlaag ↓
  1. [verwijderd] 2 maart 2017 18:44
    Good evening,

    I'm back from Venice and youpi up is back with breakage of resistances. What a beautiful day, we finish at 0.319 and speculation will start. But why so suddenly rise? Re-read my AT, my monthly AT (yesterday cross MM7 MM20), my AT weekly (the bubble was treated this week with the kiss to the MM7)

    Every day, we come in a day to break the triangle of which I spoke to you every day. This break resulted in the passage of the MM7, the MM20, the tenkan, the SAR break (look at the red dots have been transformed into 1 green dot below the candle). Now there is only a mini resistance at 0.326 look at my trait (the highest closing of the last months on 30/01/2017). When we close them (0.326) we will quickly go to the attack of 0.366 (highest price in recent months).

    In weekly, now this MM7 weekly is a big support and should soon propel Pharming group like a trampoline above the last highest to 0.366, I think about the 0.43. The rise can not resume until the volume returns. But the rise will be triggered by what? Great results on March 09? Speculation before results? A news?

    To summarize my triangle valid until March 03 was broken as well as all short-term resistances except the 0.326. The bubble is treated, the mm7 mm20 monthly crossed, I let you guess the sequence of events ....

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there

    Good night

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  2. [verwijderd] 3 maart 2017 01:20
    quote:

    cucugno schreef op 2 maart 2017 18:44:

    Good evening,

    I'm back from Venice and youpi up is back with breakage of resistances. What a beautiful day, we finish at 0.319 and speculation will start. But why so suddenly rise? Re-read my AT, my monthly AT (yesterday cross MM7 MM20), my AT weekly (the bubble was treated this week with the kiss to the MM7)

    Every day, we come in a day to break the triangle of which I spoke to you every day. This break resulted in the passage of the MM7, the MM20, the tenkan, the SAR break (look at the red dots have been transformed into 1 green dot below the candle). Now there is only a mini resistance at 0.326 look at my trait (the highest closing of the last months on 30/01/2017). When we close them (0.326) we will quickly go to the attack of 0.366 (highest price in recent months).

    In weekly, now this MM7 weekly is a big support and should soon propel Pharming group like a trampoline above the last highest to 0.366, I think about the 0.43. The rise can not resume until the volume returns. But the rise will be triggered by what? Great results on March 09? Speculation before results? A news?

    To summarize my triangle valid until March 03 was broken as well as all short-term resistances except the 0.326. The bubble is treated, the mm7 mm20 monthly crossed, I let you guess the sequence of events ....

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there

    Good night

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
    Thanks again for your clear contribution.
  3. [verwijderd] 3 maart 2017 20:07
    Good evening,

    A week as I like them, we put everything in place every day, weekly, monthly to make room for movement next week, why am I saying this? Read the reasons below.

    On a daily basis we came out yesterday from the top of my triangle and we still need a confirmation candle and we got it because tonight we did not get back into the triangle so farewell triangle. All the resistances broken yesterday have become supports so good news there is only a short term resistance and it is still the same, the evidence today it has still blocked us. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). When we close them (0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, I am happy, the bubble has finally been dealt with this week, look at the magic of the AT. To remind bubble weekly January 30 and I had said big drop to reintegrate the bollingers then kisses to the MM7 weekly. It took 4 weeks to do all this, 4 weeks lost or it was impossible to start strongly upwards. The bubble being treated, we are therefore in place to start again towards the highest of 2017 the 0.366. The MM7 hebdo was this week at 0.308, next week it will be towards 0.32, I will tell you that Monday night, which means it will serve us as a support to leave. For next week, results Thursday at 7 o'clock so hectic week, even if we had to fall it must Friday remain close above the cloud at 0.277 so that the medium-term rise is not called into question. Watch out for your stops on Monday. The weekly is therefore always very bullish with no resistance on the horizon.

    To summarize the daily and the weekly are very bullish, just to pass the 0.326 to attack the 0.366 then the 0.43 (monthly cloud). This week the MM7 monthly crossed the MM20 monthly upward so optimal configuration that warns us of the imminent arrival of a new leg of rise

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual technical analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult to move and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we went back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there

    Good night

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
  4. [verwijderd] 6 maart 2017 18:05
    Good evening,

    New week that begins with for many the expectation of takeoff for the 2016 results unveiled Thursday March 09 at 07 hours on the website of pharming group.
    As I have been saying for weeks, 2016 is the past under the influence of Valéant who was in bad shape so nothing surprising to expect from these results. On the other hand, the turnover of the first quarter unveiled on May 17 will certainly be booming. What to expect from Thursday then, an indication on the month of December or Valéant was no longer among us around 10/12/2016, the evolution of sales in Europe and hope for information on the beginning of the year by the doctor Devries. We will wait until March 23, indeed March 23 pharming will unveil the 2016 annual report.
    Go to start the week, a drop but no impact for technical analysis as you will read below but the vise tightens.

    Every day is always bullish as we are above the MM7 0.314, the MM20 0.313, the SAR 0.285, the supertrend 0.291, the kijun 0.307, the tenkan 0.316 and the cloud 0.298. On the other hand always the 0.326 that block us, when the volume will return a break will be considered because without volume it is traders who mumuse with cents. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). When we close them (the 0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, the serious things will begin. The weekly is still very bullish with no resistance on the horizon. On the other hand our first support that we waited impatiently is there to our buttocks, it is the MM7 weekly as by chance to 0.316, closing evening tonight. As a reminder, only the close on Friday counts, we can go below this week but to preserve this medium-term rise intact it will need to close above 0.316 on Friday.

    To summarize the daily and the weekly are very bullish, just to pass the 0.326 to attack the 0.366 then the 0.43 (monthly cloud). We will be in the week in a vise between 0.316 MM7 weekly and 0.326 daily resistance, which will be the strongest ???? Last week the MM7 monthly crossed the MM20 monthly upward so optimal configuration warns us of the arrival Imminent of a new rising leg. Watch out for your STOPS orders as when the speculation starts, the roller coaster will be switched on and it would be a shame to be released on an intraday move.

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we went back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10 years down taking it to the bottom of the hole close to 0 and since we are there Good eveningTo finish I specify that I own 500,000 shares, that I do not give purchase advice Or sales and that my AT is purely informative (sorry for this small sentence that serves to protect me from malicious spirits)
    cucugno
    http: //www.actionnaires-pharming-group.sitew.fr/
  5. [verwijderd] 7 maart 2017 18:13
    Good evening,

    A bit of reading to begin with, an EMA report of 06/02/2017 that I found today including the auto administration of the ruconest:
    www.ema.europa.eu/docs/en/EN/document...
    Then, an account of the pharming group exhibition in Atlanta last weekend:
    www.oncologynurseadvisor.com/aaaai-20...

    New day of stagnation with for many the expectation of take-off for the results 2016 unveiled Thursday 09 March at 07 hours on the website of pharming group.
    As I have been saying for weeks, 2016 is the past under the influence of Valéant who was badly in point so nothing surprising to expect from these results but we never know an explosion of sales in the last quarter. On the other hand, the turnover of the first quarter unveiled on May 17 will certainly be booming. What to expect from Thursday then, an indication on the month of December or Valéant was no longer among us around 10/12/2016, the evolution of sales in Europe and hope for information on the beginning of the year by the doctor Devries. We will wait until March 23, indeed March 23 pharming will unveil the 2016 annual report.

    Today mini drops with traders at the controls, I watched the latest exchanges and we do everything to keep short-term and medium-term supports, incredible!
    On a daily basis, everything is always bullish except the tenkan because we are above the MM7 0.315, the MM20 0.314, the SAR 0.287, the supertrend 0.291, the kijun 0.306, and the cloud 0.298. The tenkan is above us at 0.316 without affect. On the other hand always the 0.326 that block us, when the volume will return a break will be considered because without volume it is traders who mumuse with cents. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). When we close them (the 0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, the serious things will begin. The weekly is still very bullish with no resistance on the horizon. On the other hand our first support that we waited impatiently is there to our buttocks, it is the MM7 weekly as by chance to 0.315, closing night tonight. As a reminder, only the close of Friday counts, we can go below this week but to preserve this increase in the medium term intact it will have to close above 0.315 on Friday.

    To summarize the daily and the weekly are very bullish, just to pass the 0.326 to attack the 0.366 then the 0.43 (monthly cloud). We will be in the week in a vise between 0.315 MM7 weekly and 0.326 daily resistance, which will be the strongest ???? Last week the MM7 monthly crossed the MM20 monthly upward so optimal configuration that warns us of the arrival Imminent of a new rising leg. Watch out for your STOPS orders as when the speculation starts, the roller coaster will be switched on and it would be a shame to be released on an intraday move.

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    I am Xplicity, the annual resistance is very difficult to move and often it takes 2 to 10 years to reach them. The last time we passed above the annual MM7 was in 2005, the price had gone from 3.3 € to 2003 to 43.1 in 2006 to be about 15 times higher. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we went back below, the highest of the year was 43.1 And the lowest 8 euros, followed by a 10-year decline taking it to the bottom of the hole close to 0 and since we are there Good eveningTo finish I specify that I own 500,000 shares, which I do not give Advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the malicious spirits)
    cucugno
    http: //www.actionnaires-pharming-group.sitew.fr/
  6. [verwijderd] 8 maart 2017 18:09
    Good evening,

    A little reading to begin with, a tip to the purchase of Zacks company:
    www.thecerbatgem.com/2017/03/07/pharm...

    New day very interesting because volumes are back with big orders between 100,000 and 200,000 titles all day. This is a start of coconut shaking so tie your belts for tomorrow.
    Today small decrease with break of a few small short-term supports but no impact at the moment because tomorrow the results will make the course and in AT it always requires a confirmation candle to validate or invalidate a break of supports. Tomorrow in case of bad news, the mediums for the hike to be extended in the medium term will be 0.256 mm20 weekly and 0.277 cloud weekly, but watch out for Friday's close. The supports for that increase will extend in the long term will be 0.25 MM20 and 0.257 MM7 but attention only the closing at the end of the month counts. So tomorrow attention to stops, no panic and in case of bad news it will be necessary to observe purchases on long-term supports.

    In daily, yesterday we broke the tenkan (0.315) of the blow today with break of the MM7 (0.315) and the MM20 (0.315). We bounced on the kijun (0.306) so nothing worrying at the moment. On the other hand always the 0.326 which block us. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). When we close them (0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, the serious things will begin. The weekly is still very bullish with no resistance on the horizon. We pass under the MM7 weekly at 0.315 tonight but as a reminder, only the close on Friday counts, we can go below this week but to preserve this medium-term rise intact it will need to close above 0.315 on Friday.

    To summarize small drop tonight because of the break last night of the tenkan, now we will wait wisely the results of tomorrow at 7 o'clock on the site www.pharming.com. Last week the MM7 monthly crossed the MM20 monthly upward so optimal configuration that warns us of the imminent arrival of a new rising leg. Watch out for your STOPS orders as when the speculation starts, the roller coaster will be switched on and it would be a shame to be released on an intraday move.

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode.
    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.

    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there

    Good night

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  7. [verwijderd] 9 maart 2017 18:02
    Good evening,

    Finally we had our annual results with a good increase in turnover and good news for the future, look at the PDF of the day above the forum (results 2016, release in French, analyst report who still sees it To 0.66 €). The good news is the explosion of the turnover to come without Valéant to which we paid enormous sums, clinical trials to come for the auto-injection of the ruconest, the profitability of operation planned for 2017, according to Stifel news Of the FDA before mid 2017 .....

    Today, as often the days of results we witnessed a shake of coconut palms all this to finish practically in balance but with many volumes, I will not be surprised to learn in a few days that the hedge fund managed By Mr. Gerber our principal partner sold a few million shares, it may have had them at 0.205. Always the 0.326 which block us, we hit them at the opening and boom direction 0.30.

    In daily, big jerks and our savior was the top of the ichimoku cloud at 0.30. I remind you when we are at the top it means we are bullish. We are below tenkan (0.313), MM7 (0.314) and MM20 (0.315). It may be that we are in a range between 0.30 and 0.326, to be confirmed in the next few days. On the other hand always the 0.326 which block us. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). This kind of range is called lateralization. When we close them (0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, the serious things will begin. The weekly is still very bullish with no resistance on the horizon. We pass under the MM7 weekly at 0.314 tonight but as a reminder, only the close on Friday counts, we can go below this week but to preserve this medium-term rise intact it will need to close above 0.314 on Friday. So rendezvous tomorrow to see if we reintegrate it.

    To sum up as expected it was the roller coaster with no damage at the moment even though the short term is negative for 2 days. Tomorrow it will be necessary to close above the MM7 weekly at 0.314 so that the medium-term rise resumes its road towards the 0.366

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years.
    Why?
    Look at this annual chart:
    www.noelshack.com/2017-09-1488218378-...

    Look at the annual AT because it is a very very long term AT and there is something very important to say.

    The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM.
    Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them.
    The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high ....
    To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there

    Good night

    Finally I specify that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence that servesTo protect me from malicious spirits)
    cucugno
    www.actionnaires-pharming-group.sitew...
  8. [verwijderd] 10 maart 2017 18:04
    Good evening,

    Last weekend, week of results without surprise, we now expect more news and the turnover of the first quarter unveiled in May. Today Roth Capital has done a new analysis of Pharming group with a goal of 1.30 € (see the PDF above the forum). All analysts' opinions are at the top of the board, the forecast is 0.66 € to 1.40 € so we have margin.

    Today, new small drop following the breakdown of short-term resistances. Little bad news in weekly not very bad but I must explain it to you below.

    In daily, nothing new today, the cloud at 0.30 as yesterday allows us to stay bullish in the short term in ichimoku. The kijun at 0.306 served as a support. On the other hand, we still have a few resistances, we are below tenkan (0.313), MM7 (0.314) and MM20 (0.316). It may be that we are in a range between 0.30 and 0.326, to be confirmed in the next few days. On the other hand always the 0.326 which block us. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). This kind of range is called lateralization. When we close them (0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly news, bad news this Friday we close below the MM7 to 0.314 which supported us since January 2, 2017, that does not mean that we pass bearish in the medium term, just we risk next week to go to test the Medium-term mediums: tenkan at 0.294, kijun at 0.284, cloud at 0.277 and at worst at mm20 at 0.256. Attention in technical analysis it is always necessary a candle of confirmation so it is possible that next Friday we pass our MM7.

    To summarize results week in line with expectations, before when Pharming announced results it dropped, now it stagnates it is better .... We broke a small weekly support so to confirm next Friday if false output or drop to other Supports. The medium and long term increase is not questioned, the supports are present and await the trigger.

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take him to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  9. [verwijderd] 13 maart 2017 18:09
    Good evening,

    New week, which begins in the red and it was predictable with last Friday's close under the MM7 weekly. To begin with despite the decline in recent days, the average and long-term increases are not challenged. It's just the short-term trend that has worsened since last week. To be called into question it would be necessary to close under the MM30 weekly to 0.245 on Friday and under MM20 monthly to 0.255 therefore one realizes that one has margin even if many are disappointed that it does not rise in straight line. As I often say it will suddenly rise for an FDA-like news or an explosion of first quarter sales. Regarding the FDA, here is a very interesting link to read, posted by Ozzo that I thank: biotechbourse.fr/changements-a-fda-po...

    In daily, small degradation at the level ichimoku, because we returned to the cloud so the trend is neutral instead of bullish. On the other hand, we still have a few resistances, we are below the kijun (0.306), the top of the cloud (0.307), the tenkan (0.31) of the MM7 (0.311) and the MM20 (0.315). I told you about a range last week between 0.30 and 0.326 and it would seem that it is confirmed, if we are in a range tomorrow we should bounce back to stay there. On the other hand if we break the 0.30 tomorrow we will test the supertrend at 0.291 to and the SAR at 0.292. Always the 0.326 that block us. These are the 0.326 watch my trait (highest closing of the last months on 30/01/2017). This kind of range is called lateralization. When we close them (0.326) we will quickly go to the attack of the 0.366 (highest course of the last months) so watch well its passage because it will accelerate strong later.

    In weekly, we are now below the MM7 at 0.31 which supported us since January 2, 2017, that does not mean that we pass bearish in the medium term, just we risk this week to go to test the medium medium term : Kijun at 0.286, cloud at 0.277 and at worst mm20 at 0.259. Attention in technical analysis it is always necessary a candle of confirmation so it is possible that next Friday we pass our MM7 and that the break is invalidated. For the medium-term rise to be questioned would have to close Friday under the MM30 at 0.245, we see that we have margin and that it blows the merry.

    To summarize bad early week, we are in a daily range and we will see if we are ripe for a rebound tomorrow. The medium and long term increase is not questioned, the supports are present and await the trigger.

    Here is the daily and weekly chart below:
    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested on Pharming group for its fundamentals and only one news will take it to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I specify that I own 500,000 shares, that I do not give advice of purchase or Of sale and that my AT is purely informative (sorry for this little sentence that serves to protect me from the evil spirits)
    cucugno
    http: //www.actionnaires-pharming-group.sitew.fr/
  10. [verwijderd] 14 maart 2017 18:20
    Good evening,

    What a day we are experiencing our first jolts since the creation of this forum and I thank you for your knowledge to live even in times of panic for some. Tonight I will be even more technical than usual so that you understand that despite this decline in recent days, the average and long term increase is not at all questioned. In 2014 we had experienced shocks but the annual graphic configuration was not optimal as this year. We have fallen today but we have rebounded strongly on the medium and long term mediums .. For the medium and long term increase to be questioned it would be necessary to close under the MM30 weekly at 0.245 on a Friday and under MM20 monthly at 0.255 So we realize that we have margin even if many are disappointed that it does not rise in a straight line. As I often say it will suddenly rise for an FDA-like news or an explosion of first quarter sales. In the middle of the day we had this interesting article and right after it left: www.satprnews.com/2017/03/14/heredita... -2025-persistence-market-research /

    On a daily basis, we were in a range between 0.30 and 0.326. Today this range is obsolete because we went out from below. What is good is that when we break a range we must reach a bearish objective corresponding to the height of the range, good news in one day we broke the range and reached the bearish target. On a daily basis virtually everything is bearish now except for the supertrend that held the shock at close to 0.291. We just made a T2 (second fence out bollingers with bollingers that diverge), it is possible that tomorrow we would make a T3.

    In weekly newspapers, yesterday I said that: we are now below the MM7 at 0.31 which supported us since January 2, 2017, that does not mean that we pass bearish in the medium term, just we risk this week to go test The following medium-term mediums: kijun at 0.286, cloud at 0.277 and at worst mm20 at 0.259. Attention in technical analysis it is always necessary a candle of confirmation so it is possible that next Friday we pass our MM7 and that the break is invalidated. For the medium-term rise to be questioned would have to close Friday under the MM30 at 0.245, we see that we have margin and that it blows the merry.
    We see today that we tested the kijun at 0.286 and the cloud at 0.277 and the miracle big rebound but why? For going under under closing Friday would mean that we are no longer bullish in the medium term but neutral. Computers are not crazy about or rebound on these levels to not invalidate the medium term.
    A new thing I will talk about today because many people think that an action must go in a straight line, we would all like it but it is not. I explain when we climb strongly like us in January, the action must breathe in stages called the retracements of fibonacci, for the plots it is simple I took the low of June 20, 2016 at 0.15 and The highest of January 2017 at 0.366 and then you will see that there are levels, only the close of Friday counts because it is of the weekly. Basically if Friday closes below a level the following week we will test the following. I'm not telling you we'll go back to 0.15 but the beautiful needs to blow without invalidating the medium-term rise, look at this chart:
    www.noelshack.com/2017-11-1489510887-...
    Then in weekly the rise is not questioned as long as one is not under the MM30 weekly, look at this graph it is at 0.245:
    www.noelshack.com/2017-11-1489510951-...
    Watch the Tradosaure video that will tell you about this MM30 for pharming group:
    tradosaure-trading.blogspot.fr/2017/0...

    To understand the rebound during the fall and to show you that the long term is always bullish, look at this monthly chart or only the close of March 31 will count:
    www.noelshack.com/2017-11-1489511081-...
    The rebound took place in the day 0.277 on a long-term support the Kijun

    To summarize big jerks today with daily range out from the bottom with intraday technical rebound on medium and long term supports.
    The rise is still not questioned for 2017.

    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital which it held, ie approximately 30 million shares Sold between the end of January and the 6th of February, or the fall during this period. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual technical analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested on Pharming group for its fundamentals and only one news will take it to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  11. [verwijderd] 15 maart 2017 18:04
    Good evening,

    Finally we have our green candle every day, it's good after 7 fall sessions, traders have, during the last few minutes, pulled out the heavy artillery with big orders to buy.
    The week is not over and do not forget that for the weekly chart only the closing counts. To understand why analysts expect a turnover of more than 50 million in 2017, which is huge compared to our usual 10 to 15 million, read the post on this forum "jobs at pharming", you will see The incredible expansion of the sales force in the world.

    On a daily, good news thanks to the last minutes of quotation we have reinstated the bollingers and when they reintegrate the courses will see the MM7 which is tonight at 0.305. So tomorrow direction MM7. In daily we have two holders that held the shock, 0.291 the supertrend and 0.286 the bottom of the ichimoku cloud that allowed the rebound today because at the lowest we were at 0.287. There is still a short-term job to shoot up, it will be necessary to pass the tenkan at 0.301, the kijun at 0.303, the mm7 at 0.305, the mm20 at 0.312, the sar at 0.325 and finally break the 0.326 Of recent months). When we break the 0.326 in closing we will go towards 0.366 the highest of 2017.

    In weekly, only Friday's close, we are below the MM7 at 0.31 since last Friday but be careful in technical analysis it is always necessary a confirmation candle so why not finish above 0.31 in two days and invalidate the break. We can see the strength of the rebound on the cloud ichimoku hebdo hit yesterday at 0.277, the stock is still very bullish despite the shocks. I remind you that for the medium-term increase to be called into question we should close Friday under the MM30 at 0.245, we see that we have margin and that it blows the memorial.

    To summarize the rebound took place finally after 7 sessions of decline, thanks to medium and long term medium always very bullish. The close of Friday will be very important for next week, publication of the 2016 accounting report on March 23.

    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take him to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  12. [verwijderd] 16 maart 2017 17:44
    Good evening,

    Before starting, read on this forum the post called: "pharming in the race for". You will find superb information given by Gilles and Fabrice on other studies in progress at pharming group. The newest addition to the site, now our share price is displayed live.

    Nice day for our pharming, which breaks daily resistance since Tuesday's low.
    The week is not over and remember that for the weekly chart only the close count therefore why not go tomorrow at the top of the MM7 at 0.311. To understand why analysts expect a turnover of more than 50 million in 2017, which is huge compared to our usual 10 to 15 million, read the post on this forum "jobs at pharming", you will see The incredible expansion of the sales force in the world.

    On a daily basis, she is on the way to healing the little one, we go back over the blue ichimoku cloud at 0.30 and above the kijun at 0.301 which means that we are again bullish with regard to ichimoku. We have some resistance to pass to attack the 0.326 again and finally break them (the highest closing of these last months). When we break the 0.326 in closing we will go towards 0.366 the highest of 2017. The resistances for tomorrow will be the kijun and the mm7 to 0.303, the mm20 to 0.311 and the SAR to 0.324

    In weekly, only Friday's close, we are below the MM7 at 0.311 since last Friday but be careful in technical analysis it always requires a confirmation candle so why not finish above 0.311 in tomorrow and invalidate the break. We can see the strength of the rebound on the cloud ichimoku hebdo hit yesterday at 0.277, the stock is still very bullish despite the shocks. I remind you that for the medium-term increase to be called into question we should close Friday under the MM30 at 0.245, we see that we have margin and that it blows the memorial.

    To summarize continuation of the rebound, thanks to the medium and long term medium always very bullish. The close of Friday will be very important for next week, publication of the 2016 accounting report on March 23.

    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested on Pharming group for its fundamentals and only one news will take it to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    www.actionnaires-pharming-group.sitew...
  13. [verwijderd] 17 maart 2017 17:52
    Good evening,

    Before starting, read on this forum the post called: "mail sent to Mr Devries". You will find a copy of the mail sent this day to inform it of the existence of our forum with more than 3.5% of the capital in our hands. Enjoy to re-read analyst reports this week end, they are at the top of the forum, they are very informative about the coming turnover, the next important dates, the clinical developments at pharming group. Enjoy also to re-read the annual AT showing that above the MM7 at 0.34, it is the paradise that awaits us for several years. This week will be the publication of the annual report 2016, on March 23, 2017 at 7 o'clock on the official website of our nugget.

    What a hectic week, with a rebound on the long-term supports that makes it possible to finish the week practically at equilibrium. This decline was announced last Friday because of the breakdown of the MM7 weekly. Despite the violent movements of the week, the average and long-term rise is still valid, the short-term rise is set aside for a few days, time to break the technical resistances above our heads.

    Every day, we finish the week, we are at the limit of the blue ichimoku cloud at 0.30 and above the supertrend at 0.291. We have some resistance to pass to attack the 0.326 again and finally break them (the highest closing of these last months). When we break the 0.326 in closing we will go towards 0.366 the highest of 2017. The resistances for Monday will be the tenkan 0.301, the mm7 to 0.301, the kijun to 0.303, the mm20 to 0.31 and the SAR to 0.323

    In weekly, everything is very bullish over the medium term except resistance MM7 at 0.31 and now the Tenkan at 0.305 it will be our next goal to close up next Friday.
    The strength of the rebound on the weekly ichimoku cloud hit Wednesday at 0.277, the action is still very bullish despite the jolts. I remind you that for the medium-term increase to be called into question we would have to close a Friday under the MM30 which this week is at 0.245, we see that we have margin and that it still blows the nugget.
    To understand the graph and the reason for the rebound, look at the accuracy of the rebound on the green cloud at 0.277 but why? If we had closed below 0.277 the stock would have become neutral in the medium term instead of bullish or rebound through purchases mainly robots.

    To summarize very hectic week with bounce on the long-term supports. Only the short term is a little degraded. I remind you that the 0.326 serve as resistance and that when they are closed we will return to the highest of 2017 to 0.366 then to the monthly long-term cloud at 0.43 (to understand re-read on the forum the monthly AT) .

    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of the ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take it to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno
    [Modbreak IEX: Gelieve hier geen reclame te maken, bericht is bij dezen aangepast.]
  14. [verwijderd] 20 maart 2017 17:52
    Good evening,

    Before we started, we received a reply by e-mail from Mr. Devries that I let you discover in the forum, we will now be in touch with his colleague Susanne Embleton.
    Also read the topic entitled "Answer", it is an answer that received Bocule to his mail to Mr. Devries.
    This week we will have the 2016 annual report which will be unveiled on March 23rd.

    New week that begins with a small drop, I remind you that despite the violent movements last week, the increase in the medium and long term is still valid, the short-term increase is set aside for a few days, time To break the Resistances above our heads. Attention new appears in the short term, look below.

    On a daily basis we are now in a big triangle with a maximum release on April 10th that will do damage according to the direction of the exit. The daily is always bearish or neutral according to the indicators. We are in the blue ichimoku cloud whose top is at 0.299 neutral version ichimoku. We are above the trend above 0.291. We have some resistance to pass to attack again the 0.326 and finally break them (the highest closing in recent months). When we break the 0.326 in closing, we are going towards 0.366 the highest of 2017. The resistances for Tuesday will be the tenkan 0.301, the top of the cloud at 0.299, the mm7 at 0.299, the kijun at 0.303, the mm20 at 0.309 and La SAR at 0.322

    In the week, everything is very bullish on the medium term, except the resistance of the MM7 to 0.307 and now the Tenkan to 0.316, this will be our next goal to close next Friday.
    We can see the strength of the rebound on the weekly cloud ichimoku reached last Wednesday at 0.277, the stock is still very bullish despite the shakes. I remind you that in order for the medium-term increase to be questioned, we should close a Friday under the MM30 which is this week at 0.247, we see that we have margin and that it still blows the nugget.
    To understand the graph and the reason for the rebound, look at the accuracy of the rebound on the green cloud at 0.277, but why? If we had closed below 0.277, the stock would have become neutral in the medium term instead of bullish or rebound through purchases mainly of robots.

    To summarize the short term is still bearish, but beware there is a triangle with an exit no later than April 10, to watch. I remind you that the 0.326 serve as resistance and that when they are closed we will return to the high of 2017 to 0.366 then to the long-term monthly cloud to 0.43 (to understand the re-reading on the forum the monthly AT).

    www.actionnaires-pharming-group.sitew...

    In addition to the AT we will talk about several things (I put it every day for new):

    - Our main shareholder, hedge fund, sold 7% of our capital, or about 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the increase will be retained
    - a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure at 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for auto-injection of ruconest will take place
    - Analysts' views are at the top of the board, they range from € 0.66 to € 1.40

    I return for the newcomers the annual technical analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the gates of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of The stock market knows it. Look at the chart below showing the proximity of Pharm and the MM7 at 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action surely already started its flight but its flight will last a few years. It is not the graphics that make the courses, but the courses that make the graphics. So I'm not a diviner, I invested in the Pharming group for its fundamentals and only one news will take it to paradise, the FDA, the explosion of turnover, the new drug, the US military , Transplantation ...

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno (David)
    [Modbreak IEX: Gelieve hier geen reclame te maken, bericht is bij dezen aangepast.]
  15. forum rang 10 voda 20 maart 2017 18:01
    Huh? ik geloof mijn eigen ogen niet. Alle andere posts zijn van deze draad verwijderd, zelfs mijn vriendelijke uitleg aan sproetje!

    Totaal boycotten deze draad!!! Niet eens meer openen!
  16. [verwijderd] 20 maart 2017 18:12
    quote:

    voda schreef op 20 maart 2017 18:01:

    Huh? ik geloof mijn eigen ogen niet. Alle andere posts zijn van deze draad verwijderd, zelfs mijn vriendelijke uitleg aan sproetje!

    Totaal boycotten deze draad!!! Niet eens meer openen!
    Ik snap het beleid van IEX sowieso niet altijd even goed: ik meen dat (verkapt) reclame maken voor een ander forum niet is toegestaan. Dus hier ook niet.
  17. [verwijderd] 20 maart 2017 18:45
    quote:

    voda schreef op 20 maart 2017 18:01:

    Huh? ik geloof mijn eigen ogen niet. Alle andere posts zijn van deze draad verwijderd, zelfs mijn vriendelijke uitleg aan sproetje!

    Totaal boycotten deze draad!!! Niet eens meer openen!
    Rare reactie op een geweldige draad met relevante informatie.
    ??????
  18. [verwijderd] 21 maart 2017 18:03
    Good evening,

    Before starting, I wanted to thank you for your confidence, for the atmosphere on the forum. We now hold 4% of the capital and each day new shareholders join us. Thanks to Danielle for counting the number of shares. Before starting, a new article to read or the ruconest is cited: www.medgadget.com/2017/03/recent-repo...
    This week we will have the 2016 annual report which will be unveiled on March 23 with hopefully an indication on the activity of the first quarter of 2017.

    New day of decline with the supports that still hold, I remind you that despite the violent movements last week, the medium and long term increase is still valid, the short-term rise is set aside for a few days, Break the technical resistances above our heads. Yesterday I told you that we were in a triangle and in addition to this triangle as Vincent and David (Jeanroul82) pointed out to us we are in a channel, I explain this below.

    On a daily basis, we are now in a big triangle with a maximum output on April 10th that will do damage according to the direction of exit. In addition to this triangle, there is a channel between 0.294 and 0.326 why? Since the strong increase of January 23, we always close between 0.294 and 0.326, look at the graph and you will understand. Normally if we follow the logic tomorrow we will rebound on the bottom of this channel, even if we go below in the day, only the close counts. In case of break from the bottom we will go towards 0.262 and in case of break from the top we will go towards 0.358 therefore attention. The daily is always bearish see neutral according to the indicators. We are in the blue ichimoku cloud whose top is at 0.302 so neutral version ichimoku. We are above the supertrend at 0.291 which allowed us to rebound today. We have some resistance to pass to attack the 0.326 again and finally break them (the highest closing of these last months). When we break the 0.326 in closing we will go towards 0.366 the highest of 2017. The resistances for Wednesday will be the tenkan 0.301, the top of the cloud at 0.302, the mm7 at 0.298, the kijun at 0.303, the mm20 at 0.308 and the SAR At 0.321.

    In weekly, everything is very bullish on the medium term except resistance the MM7 at 0.307 and now the Tenkan at 0.316 it will be our next goal to close up next Friday.
    We can see the strength of the rebound on the ichimoku weekly cloud hit last Wednesday at 0.277, the stock is still very bullish despite the jolts. I remind you that for the medium-term increase to be called into question we should close a Friday under the MM30 which this week is at 0.247, we see that we have margin and that it still blows the nugget.
    To understand the graph and the reason for the rebound, look at the accuracy of the rebound on the green cloud at 0.277 but why? If we had closed below 0.277 the stock would have become neutral in the medium term instead of bullish or rebound through purchases mainly robots.

    To sum up the short term is always bearish but beware there is a triangle with an exit no later than April 10, to watch. We are also in a range between 0.294 and 0.326. I remind you that the 0.326 serve as resistance and that when they are closed we will return to the highest of 2017 to 0.366 then to the monthly long-term cloud at 0.43 (to understand re-read on the forum the monthly AT) .

    Here are the graphs:
    www.actionnaires-pharming-group.sitew...
    www.noelshack.com/2017-12-1490115242-...

    In addition to the AT we will talk about several things (I put it every day for new ones):

    - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
    -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
    - the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
    - We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
    - Clinical trials for the auto-injection of ruconest will take place
    - Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €

    I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
    Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.

    To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take him to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....

    www.noelshack.com/2017-09-1488371561-...

    Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)

    Cucugno (David)

    [Modbreak IEX: Gelieve hier geen reclame te maken, bericht is bij dezen aangepast.]
97 Posts
Pagina: «« 1 2 3 4 5 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Macro & Bedrijfsagenda

  1. 02 mei

    1. Chinese beurzen gesloten ivm Labor Day
    2. ArcelorMittal Q1-cijfers
    3. DSM Firmenich Q1-cijfers
    4. ING Q1-cijfers
    5. BAM Q1-cijfers
    6. ForFarmers Q1-cijfers
    7. Aedifica Q1-cijfers
    8. HelloFresh Q1-cijfers
    9. Shell Q1-cijfers
    10. RELX 41,8 pence ex-dividend
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht